Major Health Insurers Post Solid Q1 Results But Q2 Looms as Real Test
CNBC reported Tuesday that major health insurers posted stronger-than-expected first-quarter results, lifting investor confidence across the sector. But analysts are warning that health insurers earnings tell an incomplete story for now.
Beats Across the Board in Q1
UnitedHealth, Elevance, Cigna and Humana all surpassed Wall Street estimates for the first quarter. Several companies also lifted their full-year 2026 outlooks alongside those results. Barclays analyst Andrew Mok attributed part of the outperformance to seasonal effects, including a mild flu season and weather-related disruptions that temporarily held down medical spending. More meaningfully, Mok noted that insurers also added to their medical reserves during the quarter, building a financial cushion that could support guidance for the rest of the year.
Why Analysts Say Q1 Data Has Limits
Baird analyst Michael Ha urged investors not to read too much into the first-quarter figures. Because of a lag in claims processing, expenses tied to hospital stays and medical procedures can take one to two months to work through the reimbursement cycle. That means insurers may only hold firm claims data from January by the time they close the quarter. “We always tell investors to take the first quarter with a grain of salt,” Ha told CNBC. The second quarter, when more complete claims data arrives, will offer a far clearer picture of whether pricing assumptions are holding and what full-year earnings may look like.
Background: Two Years of Cost Pressure
The sector’s cautious optimism follows a difficult stretch. Medicare Advantage plans, which are privately administered versions of the federal Medicare program, became a significant source of escalating costs as seniors increased their use of medical services following the pandemic. Insurers responded by exiting unprofitable markets, cutting benefits and adjusting premiums to better reflect rising expenses. UnitedHealth, for instance, announced in late 2024 that it would withdraw Medicare Advantage coverage from 109 counties beginning this year, affecting roughly 180,000 members. Those corrective steps are now showing up in medical loss ratios, a key metric measuring costs as a share of premium revenue, which came in below expectations at several companies.
The Q2 Proving Ground
Ha described the second quarter as the “real underwriting hurdle” for the sector. Clearing it successfully could signal positive earnings momentum through the remainder of 2026. Mok also highlighted that first-quarter strength was broadly based, with commercial plans benefiting from higher premiums and Medicare Advantage gaining from leaner benefit structures. Even Medicaid, facing shrinking enrollment as states tighten eligibility, showed what Mok called “surprisingly solid” cost stabilisation. Whether those improvements persist as delayed claims arrive will determine whether the sector’s recovery has real staying power.
Read Next: Fed Holds Rates Steady as Powell Flags Tariff Uncertainty
